EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered extracellular vesicles for precision renal therapy: Bioengineering strategies and clinical translation

Linru Shi, Bei Li, Wanzhu Liu, Haifeng Wu, Wenrong Xu, Cheng Ji, Hui Qian

Interdisciplinary Medicine · 2026-05 · 4 (3)

DOI: 10.1002/inmd.70116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary Medicine, online erschienen am 24.03.2026. Verfasst von Linru Shi und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) have emerged as promising nanotherapeutics for kidney diseases due to their innate biocompatibility, barrier penetration, and regenerative cargo delivery. However, native EVs face critical limitations including low drug‐loading efficiency, poor renal targeting, and batch heterogeneity, hampering their clinical utility. Recent advances in EV bioengineering—encompassing cargo loading (electroporation, transfection), membrane modification (ligand conjugation, biomimetic vesicles), and donor cell preconditioning (hypoxia, pharmacological priming)—have significantly enhanced therapeutic precision and efficacy. Integration with biomaterials (e.g., responsive hydrogels, scaffolds) further enables sustained release and targeted delivery, improving outcomes in kidney injury models. This review systematically analyzes these innovative strategies, highlighting mechanistic insights, comparative advantages, and unresolved challenges. We critically evaluate ongoing clinical trials and propose scalable manufacturing solutions and regulatory frameworks to accelerate translation. Engineered EVs represent a next‐generation platform for personalized renal nanomedicine, poised to bridge the regenerative potential with clinical reality.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Shi, L., Li, B., Liu, W., Wu, H., Xu, W., Ji, C., & Qian, H. (2026). Engineered extracellular vesicles for precision renal therapy: Bioengineering strategies and clinical translation. Interdisciplinary Medicine, 4(3). https://doi.org/10.1002/inmd.70116

Vancouver

Shi L, Li B, Liu W, Wu H, Xu W, Ji C, et al. Engineered extracellular vesicles for precision renal therapy: Bioengineering strategies and clinical translation. Interdisciplinary Medicine. 2026;4(3). doi:10.1002/inmd.70116

BibTeX
@article{Shi2026,
  author = {Shi, Linru and Li, Bei and Liu, Wanzhu and Wu, Haifeng and Xu, Wenrong and Ji, Cheng and Qian, Hui},
  title = {Engineered extracellular vesicles for precision renal therapy: Bioengineering strategies and clinical translation},
  journal = {Interdisciplinary Medicine},
  year = {2026},
  volume = {4},
  number = {3},
  doi = {10.1002/inmd.70116}
}
Kostenlos starten →